1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc XNAS: KROS

Keros Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Under Radar
about

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

Read More
18.88 -0.32 (-1.67%)
107.02% Gain from 52W Low
376.5K
XNAS Volume

XNAS 12 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Affordable Valuation
51.0 / 100
Momentum Score
Technically Neutral
52.8 / 100
Strong Performer, Under Radar These stocks have good quality scores and strong financials. They are affordably priced stocks with potential for good returns View Similar Embed DVM
Analyst Price Target
24
1Yr Price target upside is 24%
8 analysts

12

S

6

W

1

O

2

T

SWOT Analysis

Keros Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..